| NASDAQ (usa) |
|
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
| DAX (german) |
|
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
CrystalGenomics Inc (KQ: 083790)
083790 Technical Analysis
5
| As on 26th Feb 2026 083790 STOCK Price closed @ 1479.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2009.26 & Strong Sell for SHORT-TERM with Stoploss of 2390.55 we also expect STOCK to react on Following IMPORTANT LEVELS. |
083790STOCK Price
| Open | 1300.00 | Change | Price | % |
| High | 1595.00 | 1 Day | 176.00 | 13.51 |
| Low | 1279.00 | 1 Week | 129.00 | 9.56 |
| Close | 1479.00 | 1 Month | 163.00 | 12.39 |
| Volume | 1741269 | 1 Year | -881.00 | -37.33 |
| 52 Week High 2580.00 | 52 Week Low 1220.00 | ||||
KQ Korea Most Active Stocks
| 047040 | 10050.00 | 14.86% |
| 047040 | 10050.00 | 14.86% |
| 032980 | 302.00 | 16.15% |
| 007460 | 431.00 | -6.71% |
| 007460 | 431.00 | -6.71% |
| 018880 | 4785.00 | 5.63% |
| 018880 | 4785.00 | 5.63% |
| 036540 | 8340.00 | 16.32% |
| 036540 | 8340.00 | 16.32% |
| 003530 | 8530.00 | 4.02% |
KQ Korea Top Gainers Stocks
KQ Korea Top Losers Stocks
| 083790 Daily Charts |
083790 Intraday Charts |
Whats New @ Bazaartrend |
083790 Free Analysis |
|
|
083790 Important Levels Intraday
| RESISTANCE | 2087.93 |
| RESISTANCE | 1892.64 |
| RESISTANCE | 1771.93 |
| RESISTANCE | 1651.22 |
| SUPPORT | 1306.78 |
| SUPPORT | 1186.07 |
| SUPPORT | 1065.36 |
| SUPPORT | 870.07 |
083790 Forecast February 2026
| 4th UP Forecast | 2259.44 |
| 3rd UP Forecast | 2009.15 |
| 2nd UP Forecast | 1854.44 |
| 1st UP Forecast | 1699.73 |
| 1st DOWN Forecast | 1258.28 |
| 2nd DOWN Forecast | 1103.57 |
| 3rd DOWN Forecast | 948.86 |
| 4th DOWN Forecast | 698.57 |
083790 Weekly Forecast
| 4th UP Forecast | 2124.55 |
| 3rd UP Forecast | 1917.52 |
| 2nd UP Forecast | 1789.55 |
| 1st UP Forecast | 1661.58 |
| 1st DOWN Forecast | 1296.43 |
| 2nd DOWN Forecast | 1168.46 |
| 3rd DOWN Forecast | 1040.49 |
| 4th DOWN Forecast | 833.46 |
083790 Forecast2026
| 4th UP Forecast | 4309.76 |
| 3rd UP Forecast | 3401.92 |
| 2nd UP Forecast | 2840.76 |
| 1st UP Forecast | 2279.61 |
| 1st DOWN Forecast | 678.4 |
| 2nd DOWN Forecast | 117.24 |
| 3rd DOWN Forecast | -443.92 |
| 4th DOWN Forecast | -1351.76 |
CrystalGenomics Inc ( KQ Korea Symbol : 083790 )
Sector : N/A And Other Stocks in Same Sector
Sector : N/A And Other Stocks in Same Sector
083790 Other Details
| Segment | EQ | |
| Market Capital | 279123623936.00 | |
| Sector | ||
| Industry | ||
| Offical website | > echo $website ; ?> | |
083790 Address
![]() |
||
083790 Latest News
083790 Business Profile
CrystalGenomics, Inc., a biopharmaceutical company, discovers and develops structural chemoproteiomics-based drugs in Korea. Its lead development candidate is NSAID (CG100649), which is a tissue specific anti-inflammatory agent with cardiovascular, gastrointestinal, and renal safety profiles that has completed Phase IIa clinical trial. The company's drug candidates also include CG200745, a histone deacetylase inhibitor for cancer, which is in Phase I clinical trial; and CG400549, an antibiotic candidate for methicillin resistant staphylococcus aureus and vancomycin resistant staphylococcus aureus, which is in Phase I clinical trial. In addition, it offers cloning, expression, purification, and characterization of proteins of interest; and assay and structure services. The company has drug discovery collaborations with AstraZeneca, Daiichi-Sankyo, SBI-Biotech, Carna Biosciences, Yuyu Pharma, AmorePacific, Hanmi Pharmaceuticals, and ProQuest Investments. CrystalGenomics, Inc. was founded in 2000 and is headquartered in Seongnam, South Korea. Address: Tower A, Korea Bio Park, Seongnam-si, South Korea, 463-400
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service

